309 related articles for article (PubMed ID: 27568206)
1. AKT/GSK3β Signaling in Glioblastoma.
Majewska E; Szeliga M
Neurochem Res; 2017 Mar; 42(3):918-924. PubMed ID: 27568206
[TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
Li X; Wu C; Chen N; Gu H; Yen A; Cao L; Wang E; Wang L
Oncotarget; 2016 May; 7(22):33440-50. PubMed ID: 26967052
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
6. Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence.
Mecca C; Giambanco I; Donato R; Arcuri C
Dis Markers; 2018; 2018():9230479. PubMed ID: 30662577
[TBL] [Abstract][Full Text] [Related]
7. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.
Sami A; Karsy M
Tumour Biol; 2013 Aug; 34(4):1991-2002. PubMed ID: 23625692
[TBL] [Abstract][Full Text] [Related]
9. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
13. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
Aeder SE; Martin PM; Soh JW; Hussaini IM
Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
[TBL] [Abstract][Full Text] [Related]
14. Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.
Masui K; Tanaka K; Ikegami S; Villa GR; Yang H; Yong WH; Cloughesy TF; Yamagata K; Arai N; Cavenee WK; Mischel PS
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9406-11. PubMed ID: 26170313
[TBL] [Abstract][Full Text] [Related]
15. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
[TBL] [Abstract][Full Text] [Related]
17. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
[TBL] [Abstract][Full Text] [Related]
18. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma.
Chang L; Zhao D; Liu HB; Wang QS; Zhang P; Li CL; Du WZ; Wang HJ; Liu X; Zhang ZR; Jiang CL
Mol Med Rep; 2015 Nov; 12(5):6702-10. PubMed ID: 26299938
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
Tuncel G; Kalkan R
Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
[TBL] [Abstract][Full Text] [Related]
20. GSK3β Controls mTOR and Prosurvival Signaling in Neurons.
Urbanska M; Gozdz A; Macias M; Cymerman IA; Liszewska E; Kondratiuk I; Devijver H; Lechat B; Van Leuven F; Jaworski J
Mol Neurobiol; 2018 Jul; 55(7):6050-6062. PubMed ID: 29143288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
